Monopar Therapeutics Inc. (MNPR)

NASDAQ: MNPR · Real-Time Price · USD

37.16

-2.39 (-6.04%)

At close: May 16, 2025, 4:00 PM

36.00

-1.16 (-3.12%)

After-hours: May 16, 2025, 6:46 PM EDT

Monopar Therapeutics Market Cap

Monopar Therapeutics has a market cap or net worth of $227.14 million as of May 16, 2025. Its market cap has increased by 1,902.03% in one year.

Market Cap

227.14M

Enterprise Value

172.59M

1-Year Change

1,902.03%

Ranking

#3549

Market Cap Chart

Since December 19, 2019, Monopar Therapeutics's market cap has decreased from $276.16M to $227.14M, a decrease of -17.75%. That is a compound annual growth rate of -3.55%.

Market Cap History

Date	Market Cap	% Change
May 16, 2025	227.14M	69.30%
Dec 31, 2024	134.17M	2,552.79%
Dec 29, 2023	5.06M	-83.48%
Dec 30, 2022	30.62M	-24.23%
Dec 31, 2021	40.42M	-42.33%
Dec 31, 2020	70.09M	-59.48%
Dec 31, 2019	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	673.50B
Johnson & Johnson	362.86B
AbbVie	321.75B
Novo Nordisk	289.00B
UnitedHealth Group	249.83B
Abbott Laboratories	233.35B
Novartis AG	211.47B
AstraZeneca	208.86B

Market Cap Rankings